Joshua Ziel
Algemeen Directeur bij Aerami Therapeutics, Inc.
Actieve functies van Joshua Ziel
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Algemeen Directeur | 01-06-2023 | - |
| Operationeel Directeur | 01-06-2023 | - | |
| Corporate Officer/Principal | 01-01-2022 | 01-06-2023 |
Loopbaan van Joshua Ziel
Opleiding van Joshua Ziel
| Duke University | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
- Beurs
- Insiders
- Joshua Ziel
- Ervaring
